Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NFIX antisense RNA 1 (NFIX-AS1) is a predicted long non-coding RNA transcribed antisense to the NFIX gene. Long non-coding antisense RNAs such as NFIX-AS1 are known in general to regulate gene expression at the transcriptional or post-transcriptional level, frequently through base pairing to cognate sense transcripts, modulating mRNA stability, translation, or chromatin state. While many antisense lncRNAs participate in processes such as genomic imprinting, X-chromosome inactivation, and transcriptional interference, and are increasingly implicated in cancer biology and gene regulation, there is currently no curated or experimental evidence for a validated, unique biological activity or disease association for NFIX-AS1 itself. Further study is required to establish the precise molecular function, disease relevance, and therapeutic potential of this specific lncRNA.
None documented. Mechanisms described for other lncRNA/antisense molecules include acting as a competing endogenous RNA (ceRNA), miRNA sponge, or modulating chromatin state, but no specific validated mechanism for NFIX-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NFIX antisense RNA 1 (NFIX-AS1).